HUP9701717A2 - Eljárás cPSA-meghatározására - Google Patents
Eljárás cPSA-meghatározásáraInfo
- Publication number
- HUP9701717A2 HUP9701717A2 HU9701717A HUP9701717A HUP9701717A2 HU P9701717 A2 HUP9701717 A2 HU P9701717A2 HU 9701717 A HU9701717 A HU 9701717A HU P9701717 A HUP9701717 A HU P9701717A HU P9701717 A2 HUP9701717 A2 HU P9701717A2
- Authority
- HU
- Hungary
- Prior art keywords
- cpsa
- subject
- prostate cancer
- determination
- prostate
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 abstract 2
- 102000007066 Prostate-Specific Antigen Human genes 0.000 abstract 2
- 108010072866 Prostate-Specific Antigen Proteins 0.000 abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A találmány tárgya eljárás imműnőlógiailag kiműtathatóprősztataspecifikűs antigén (PSA) kőmplexben kötött főrmáinak (cPSA)vérmintából történő meghatárőzására, kétkötőhelyű imműnőmetriásvizsgálati eljárás alkalmazásával. A találmány tárgyát képezik tővábbáeljárásők prősztatarák diagnősztizálásának elősegítésére ésprősztatarákős páciensek állapőtának nyőmőnkövetésére a találmányszerinti vizsgálati eljárás alkalmazásával.A találmány szerinti megőldás előnyösen alkalmazható a klinikaidiagnősztika területén, közelebbről a prősztatarák diagnősztizálásaterületén.ŕ
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73838396A | 1996-10-25 | 1996-10-25 | |
US83496997A | 1997-04-07 | 1997-04-07 | |
US08/903,750 US5840501A (en) | 1996-10-25 | 1997-07-31 | Determination of cPSA |
Publications (4)
Publication Number | Publication Date |
---|---|
HU9701717D0 HU9701717D0 (en) | 1997-12-29 |
HUP9701717A2 true HUP9701717A2 (hu) | 1998-05-28 |
HUP9701717A3 HUP9701717A3 (en) | 2000-04-28 |
HU221350B1 HU221350B1 (en) | 2002-09-28 |
Family
ID=27419236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9701717A HU221350B1 (en) | 1996-10-25 | 1997-10-22 | Determination of cpsa |
Country Status (14)
Country | Link |
---|---|
US (2) | US5928878A (hu) |
EP (1) | EP0838680B1 (hu) |
JP (1) | JP4274330B2 (hu) |
AT (1) | ATE267399T1 (hu) |
AU (1) | AU746345B2 (hu) |
CA (1) | CA2214488C (hu) |
CZ (1) | CZ295854B6 (hu) |
DE (1) | DE69729156T2 (hu) |
DK (1) | DK0838680T3 (hu) |
ES (1) | ES2221006T3 (hu) |
HU (1) | HU221350B1 (hu) |
IL (1) | IL121659A (hu) |
NO (1) | NO974534L (hu) |
PT (1) | PT838680E (hu) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19641560A1 (de) * | 1996-10-09 | 1998-04-16 | Boehringer Mannheim Gmbh | Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease |
CA2243033A1 (en) * | 1997-07-31 | 1999-01-31 | Bayer Corporation | Determination of psa-act |
AU1682699A (en) * | 1997-12-25 | 1999-07-19 | Japan Tobacco Inc. | Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
GB9827845D0 (en) * | 1998-12-17 | 1999-02-10 | Scolab S A | Immunoassay or proteins |
CA2311512A1 (en) * | 1999-07-24 | 2001-01-24 | Bayer Corporation | Reflex method for the detection of prostate cancer |
JP3536731B2 (ja) * | 1999-07-28 | 2004-06-14 | 富士レビオ株式会社 | HIV−1p24抗原の免疫測定方法及び試薬 |
US6569684B2 (en) | 2000-01-06 | 2003-05-27 | University Of Central Florida | Method of identifying and treating invasive carcinomas |
US6379550B1 (en) | 2000-07-24 | 2002-04-30 | Health Research, Inc. | Method for detecting PSA and its molecular forms using thiophilic gel |
ATE282205T1 (de) | 2000-07-24 | 2004-11-15 | Health Research Inc | Verfahren zur detektion von prostata-spezifischem membran-antigen in serum |
EP1307585B1 (en) | 2000-08-07 | 2009-01-21 | Vanderbilt University | Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
JP2004510161A (ja) * | 2000-09-25 | 2004-04-02 | アボット・ラボラトリーズ | 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット |
US6764825B1 (en) * | 2000-10-13 | 2004-07-20 | Tang J. Wang | Methods and device for detecting prostate specific antigen (PSA) |
US6838264B2 (en) * | 2000-12-05 | 2005-01-04 | Immutopics, Inc. | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
US7226749B2 (en) * | 2000-12-05 | 2007-06-05 | Zahradnik Richard J | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
JP4256265B2 (ja) * | 2002-03-13 | 2009-04-22 | ベーイーオー・メリュー | 循環腫瘍細胞の検出および/または定量方法、およびその方法の早期診断、予後診断、および再発診断への使用、ならびにその方法の治療的処置の選択および評価への使用 |
US20040018580A1 (en) * | 2002-05-10 | 2004-01-29 | Chai Karl X. | Synthetic substrates for prostasin |
US7666981B1 (en) | 2002-05-10 | 2010-02-23 | University Of Central Florida Research Foundation, Inc. | Inhibitors of prostasin |
US7314709B2 (en) * | 2002-08-06 | 2008-01-01 | Vanderbilt University | Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism |
EP1507147A1 (en) * | 2003-08-12 | 2005-02-16 | Erasmus University Medical Center Rotterdam | Method for detecting low levels of a fusion protein |
EP1709448B1 (en) * | 2004-01-28 | 2008-10-22 | Turun Yliopisto | Improved method for diagnosing acute coronary syndrome |
US8012694B2 (en) | 2006-09-14 | 2011-09-06 | Immutopics, Inc. | Assay for the detection of phosphorylated PTH |
EP2107377A1 (en) * | 2008-04-04 | 2009-10-07 | BRAHMS Aktiengesellschaft | Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events |
JP5415520B2 (ja) * | 2008-04-09 | 2014-02-12 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 最大酸素消費量低下の予測のためのプロ−エンドセリン−1 |
US8658164B2 (en) | 2011-11-08 | 2014-02-25 | Caldera Health Limited | Methods and materials for the diagnosis of prostate cancers |
US8632971B2 (en) | 2011-11-08 | 2014-01-21 | Caldera Health Limited | Methods and materials for determining the efficacy of prostate cancer therapies |
US20130116131A1 (en) | 2011-11-08 | 2013-05-09 | Caldera Health Limited | Methods and materials for the diagnosis of prostate cancers |
US8658166B2 (en) | 2011-11-08 | 2014-02-25 | Caldera Health Limited | Methods and materials for the diagnosis of prostate cancers |
JP6604081B2 (ja) * | 2014-08-13 | 2019-11-13 | 東ソー株式会社 | N型糖鎖が付加している膵臓リボヌクレアーゼ1の測定方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0690203B2 (ja) * | 1985-08-23 | 1994-11-14 | 中外製薬株式会社 | 前立腺特異抗原とα▲下1▼−アンチトリプシン複合体の定量方法 |
SE9002480D0 (sv) * | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
DE4322342A1 (de) * | 1993-07-05 | 1995-02-09 | Gif Ges Fuer Immunologische Fo | Verfahren für die Differentialdiagnostik des Prostata-Karzinoms |
EP0635575A1 (en) * | 1993-07-22 | 1995-01-25 | Wallac Oy | Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
US5599677A (en) * | 1993-12-29 | 1997-02-04 | Abbott Laboratories | Immunoassays for prostate specific antigen |
US5698402A (en) * | 1995-02-23 | 1997-12-16 | Dianon Systems, Inc. | Methods for diagnosing benign prostatic hyperplasia |
US5710007A (en) * | 1995-09-29 | 1998-01-20 | Luderer; Albert A. | Methods for diagnosing prostatic adenocarcinoma |
-
1997
- 1997-08-29 IL IL12165997A patent/IL121659A/xx not_active IP Right Cessation
- 1997-09-03 CA CA002214488A patent/CA2214488C/en not_active Expired - Fee Related
- 1997-09-26 AU AU39267/97A patent/AU746345B2/en not_active Ceased
- 1997-10-01 NO NO974534A patent/NO974534L/no not_active Application Discontinuation
- 1997-10-13 AT AT97117672T patent/ATE267399T1/de not_active IP Right Cessation
- 1997-10-13 PT PT97117672T patent/PT838680E/pt unknown
- 1997-10-13 EP EP97117672A patent/EP0838680B1/en not_active Expired - Lifetime
- 1997-10-13 ES ES97117672T patent/ES2221006T3/es not_active Expired - Lifetime
- 1997-10-13 DK DK97117672T patent/DK0838680T3/da active
- 1997-10-13 DE DE69729156T patent/DE69729156T2/de not_active Expired - Lifetime
- 1997-10-22 HU HU9701717A patent/HU221350B1/hu not_active IP Right Cessation
- 1997-10-23 CZ CZ19973357A patent/CZ295854B6/cs not_active IP Right Cessation
- 1997-10-24 JP JP30959997A patent/JP4274330B2/ja not_active Expired - Fee Related
- 1997-12-08 US US08/986,198 patent/US5928878A/en not_active Expired - Lifetime
- 1997-12-08 US US08/986,480 patent/US6107049A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69729156D1 (de) | 2004-06-24 |
AU3926797A (en) | 1998-04-30 |
CA2214488A1 (en) | 1998-04-25 |
PT838680E (pt) | 2004-08-31 |
HU9701717D0 (en) | 1997-12-29 |
DK0838680T3 (da) | 2004-09-27 |
ATE267399T1 (de) | 2004-06-15 |
CZ295854B6 (cs) | 2005-11-16 |
EP0838680B1 (en) | 2004-05-19 |
IL121659A (en) | 2000-07-16 |
IL121659A0 (en) | 1998-02-22 |
EP0838680A1 (en) | 1998-04-29 |
US6107049A (en) | 2000-08-22 |
NO974534L (no) | 1998-04-27 |
ES2221006T3 (es) | 2004-12-16 |
NO974534D0 (no) | 1997-10-01 |
HU221350B1 (en) | 2002-09-28 |
CA2214488C (en) | 2007-06-19 |
HUP9701717A3 (en) | 2000-04-28 |
JPH10177027A (ja) | 1998-06-30 |
US5928878A (en) | 1999-07-27 |
DE69729156T2 (de) | 2005-05-25 |
JP4274330B2 (ja) | 2009-06-03 |
AU746345B2 (en) | 2002-04-18 |
CZ335797A3 (cs) | 1998-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9701717A2 (hu) | Eljárás cPSA-meghatározására | |
DE69937368D1 (de) | Nachweis von erkrankungen der nieren und behandlung | |
DK0516746T3 (da) | Oral opsamling til immunoassay | |
ATE223051T1 (de) | Verfahren zur diagnose gutartiger prostataerkrankungen | |
DE69618447D1 (de) | Frühzeitiger nachweis von prostatakrebs (cap) durch bestimmung des konzentrationsverhältnisses zwischen prostataspezifischem antigen (psa) und menschlichem drüsenkallikrein (hgk-1) | |
ATE365922T1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
DK0807124T3 (da) | Monoklonalt antistof mod FLT4-receptor-tyrosinkinase og anvendelse heraf i diagnose og terapi | |
DE3780480D1 (de) | Test fuer menschlichen brustkrebs. | |
DE69713146D1 (de) | Helicobacter pylori diagnostika | |
ATE404676T1 (de) | Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung | |
EP1276771A4 (en) | SENSITIVE DETECTION OF EGFR MUTANTS AND GAME TYPE BY SPECIFIC ELISA DETECTION IN ANY BIOLOGICAL SAMPLE | |
ATE429440T1 (de) | Formen prostataspezifischer antigene und verfahren zu deren nachweis | |
ATE305140T1 (de) | Verfahren zur detektion der hk2 polypeptide | |
DK1200826T3 (da) | Immunoassay og testanordning med integreret reference | |
DE69811157D1 (de) | Immunoassay zur Bestimmung von PSA-ACT | |
DE3485740D1 (de) | Immunologisches testverfahren eines prokoagulierenden enzyms zum nachweis von krebs. | |
RU2001118921A (ru) | Способ мониторинга за состоянием пациентов с воспалительно-деструктивными процессами для оценки степени выраженности тканевой деструкции с помощью иммуноферментной тест-системы эли-г-иф |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |